BRIEF-Alaska Air Unveils "Alaska Accelerate," a 3-Year Plan To Drive $1 Bln In Profit After Hawaiian Airlines Merger-March 2024-www.financetom.com

BRIEF-Alaska Air Unveils "Alaska Accelerate," a 3-Year Plan To Drive $1 Bln In Profit After Hawaiian Airlines Merger

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Alaska Air Unveils "Alaska Accelerate," a 3-Year Plan To Drive $1 Bln In Profit After Hawaiian Airlines Merger

Dec 10, 2024 3:37 AM

Dec 10 (Reuters) - Alaska Air Group Inc ( ALK ):

* ALASKA AIR GROUP INTRODUCES "ALASKA ACCELERATE," ITS

THREE-YEAR

STRATEGIC PLAN TO DELIVER $1 BILLION IN INCREMENTAL PROFIT

FOLLOWING COMBINATION WITH HAWAIIAN AIRLINES

* ALASKA AIR GROUP INC ( ALK ) - EXPECTS 30% EPS GROWTH IN 2025

* ALASKA AIR GROUP INC ( ALK ) - SEES EPS TO AT LEAST $10 BY 2027

* ALASKA AIR GROUP INC ( ALK ) - SEES 2025 EARNINGS PER SHARE AT

LEAST

$5.75

* ALASKA AIR GROUP INC ( ALK ): ACQUISITION SYNERGY ESTIMATES

INCREASED TO

AT LEAST $500 MILLION BY 2027

* ALASKA AIR GROUP OUTLOOK 2025 SHARE REPURCHASES ABOUT $250

MILLION

* ALASKA AIR GROUP OUTLOOK 2025 CAPITAL EXPENDITURES $1.4 TO

$1.5

BILLION

Source text:

Further company coverage:

Previous page： Biogen, UCB Say Autoimmune Disease Drug Candidate Met Enpoint in Phase 3 Trial Next page： Hawaiian Electric Industries Prices Stock Offering

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Biogen, UCB Say Autoimmune Disease Drug Candidate Met Enpoint in Phase 3 Trial

Oct 3, 2024

04:06 AM EDT, 09/24/2024 (MT Newswires) -- Biogen (BIIB) and its collaboration partner UCB said Tuesday that a phase 3 trial of dapirolizumab pegol, intended for the treatment of patients with moderate-to-severe systemic lupus erythematosus, met its primary endpoint. The study demonstrated clinical improvement in moderate-to-severe disease activity and showed a drug safety profile, consistent with prior studies, the companies...

Hawaiian Electric Industries Prices Stock Offering

Oct 3, 2024

04:02 AM EDT, 09/24/2024 (MT Newswires) -- Hawaiian Electric Industries ( HE ) said late Monday it has priced a public offering of about 54.1 million shares of its common stock at $9.25 each. The offering is expected to close on Wednesday, subject to customary conditions. The company has granted underwriters an option to purchase up to 8.1 million additional...

InvenTrust Properties Prices Upsized $224 Million Common Stock Offering

Oct 3, 2024

04:00 AM EDT, 09/24/2024 (MT Newswires) -- InvenTrust Properties ( IVT ) said late Monday it priced an unregistered public offering of 8 million common shares at $28 per share for estimated gross proceeds of $224 million. Underwriters have been granted a 30-day option to purchase up to an additional 1.2 million common shares. The offering, which was upsized from...

T-Mobile USA to Sell $2.5 Billion of Senior Notes

Oct 3, 2024

04:14 AM EDT, 09/24/2024 (MT Newswires) -- T-Mobile US ( TMUS ) said late Monday its T-Mobile USA subsidiary has agreed to sell $2.5 billion of senior notes in a public offering. The offering includes $700 million of 4.2% senior notes due 2029, $900 million of 4.7% senior notes due 2035 and $900 million of 5.25% senior notes due 2055....